Catalyst Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
+453
| New | +$148K | ﹤0.01% | 274 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$94K | – | 384 |
|
|
2015
Q4 | $94K | Sell |
1,000
-10,000
| -91% | -$940K | 0.01% | 270 |
|
|
2015
Q3 | $884K | Sell |
11,000
-118,750
| -92% | -$9.54M | 0.12% | 143 |
|
|
2015
Q2 | $15.6M | Sell |
129,750
-70,500
| -35% | -$8.45M | 1.81% | 4 |
|
|
2015
Q1 | $20.9M | Buy |
+200,250
| New | +$20.9M | 2.4% | 1 |
|